Mobile Cessation Support for Latino Smokers
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: The Decídetext programBehavioral: Standard Care Control
- Registration Number
- NCT03586596
- Lead Sponsor
- University of Rochester
- Brief Summary
The primary aim of this study is to examine the efficacy of Decídetexto, an innovative mobile smoking cessation intervention that incorporates two elements: 1) a tablet-based e-Health platform that collects personal smoking-related information to support the development of an individualized quit plan and guides the ensuing text messaging program; and 2) a 12-week text messaging "skills-based counseling" (I.e, behavioral support) program that includes educational information, behavioral strategies, motivational messaging, and pharmacotherapy support driven by information obtained from both the tablet program and the user's text messages. The investigators will evaluate its efficacy relative to a standard care condition that provides high quality printed smoking cessation materials along with referral to telephone quit line counseling. Participants in both groups are given access to free pharmacotherapy via a toll-free study number. Experienced Promotores de Salud (Community Health Workers) will use community and clinic-based outreach to recruit Latino smokers into the study. Participants in both conditions will complete follow-up assessment at the end of treatment (Week 12) and Month 6 (primary outcome). Our hypothesis is that at month 6, smokers in Decídetexto will have significantly higher cotinine-verified 7-day point prevalence abstinence (no cigarettes in the past 7 days) than smokers in the control arm.
- Detailed Description
Latinos are less likely than non-Hispanic whites to have access to healthcare, to have knowledge of existing smoking cessation resources, to receive advice to stop smoking, and to utilize pharmacotherapy to stop smoking. Despite these marked tobacco-related disparities, there is a lack of effective interventions designed for the Latino community. Mobile technology provides a promising method for overcoming barriers and providing culturally congruent treatment to Latino smokers. Implementation of mobile interventions among Latinos remains minimal despite the fact that Latinos are the fastest adopters of mobile technology, utilizing smartphones and text messaging at a higher rate than non-Hispanic whites do. An effective, culturally appropriate intervention using mobile technologies methods with the potential for widespread adoption by clinic and community-based service providers could dramatically increase reach and impact on Latino health.
Decídetext is a culturally congruent method for increasing access to cessation services for Latino smokers and helping them develop, implement, and follow a personalized quit plan. If successful, this intervention could be readily implemented in different settings including community settings, clinics, pharmacies, emergency rooms, and clinic waiting areas and reduce treatment disparities, reduce tobacco-related morbidity and mortality, and improve the health and quality of life for approximately 9 million of Latino smokers in the United States.
Aim 1. To evaluate the impact of the culturally accommodated Decídetext program versus standard care on smoking abstinence at Month 6 among Latino smokers. At Month 6, smokers in Decídetext will have significantly higher cotinine-verified 7-day point prevalence abstinence (no cigarettes in the past 7 days) than smokers in the control arm. Program efficacy also will be examined at Week 12 (end of treatment) to assess mechanisms of change, and Month 12 to provide extended outcome data.
Aim 2. To assess therapeutic alliance, pharmacotherapy utilization, and self-efficacy as mediators of the presumed treatment effect on cotinine-verified 7-day smoking abstinence at Month 6 among Latino smokers. Our hypothesis is that Decídetext will have greater efficacy for smoking cessation than standard care by increasing therapeutic alliance, utilization of pharmacotherapy, and self-efficacy to quit.
Aim 3. To conduct a process evaluation that can inform findings and future improvements. The evaluation of Decídetext includes: 1) satisfaction with the program and its components; 2) text-message system utilization patterns and common content themes in text message interactions among participants.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 457
- Are you Hispanic or Latino?
- Do you know how to read and speak English and/or Spanish?
- Are you at least 21 years old?
- Have you smoked cigarettes for at least 6 months?
- Within a typical week, how many days do you smoke (even a puff)?
- Within a typical week, how many days do use other tobacco products?
- Are you interested in quitting smoking in the next 30 days?
- Are you currently participating in any other smoking cessation program or taking any type of medication to quit smoking?
- Is any household member participating in this study?
- Are you pregnant, breast-feeding or planning to become pregnant in the next year?
- Are you planning to move out of your current address in the following six months?
- Do you have an active cellphone with unlimited text messaging capability?
- Are you willing to come to 2 study visit, at the beginning and 6 month, and get at least 1 phone calls between visits?
- Do you know how to send/read text messages?
- Is the participant ELIGIBLE? If NOT ELIGIBLE, complete demographics If ELIGIBLE, complete contact information.
- Include plans to move from New Jersey in the next 6 months
- If another household member enrolled in the study.
- If answers no to any question of the Eligibility form.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description The Decídetext program The Decídetext program Participants will receive a tablet-based interactive educational session, 6 months of text-messaging based counseling, which includes prompts to access free pharmacotherapy. Standard Care Control Standard Care Control Participants will receive an adapted version of standard printed smoking cessation educational materials from the American Cancer Society and, the National Cancer Institute, which include information about the health risks of smoking, benefits \& strategies for quitting and access to free pharmacotherapy by calling a free number.
- Primary Outcome Measures
Name Time Method Cotinine-verified 7-day point prevalence at 6 months. 6 months Participants who quit will do a cotinine-verified 7-day point prevalence check at Month 6.
- Secondary Outcome Measures
Name Time Method 12- week self-report 12 weeks Participants in both conditions will complete follow-up assessment at the end of the treatment at 12 weeks.
Trial Locations
- Locations (3)
Hackensack Meridian Health - Hackensack University Medical Center
🇺🇸Hackensack, New Jersey, United States
University of Rochester Medical Center
🇺🇸Rochester, New York, United States
University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States